Vivek Jain sold $2.0M of ICUI
Chairman and CEO at ICU MEDICAL INC/DE. 12,000 shares at an average of $162.91, traded Dec 2, 2024, filed Dec 2, 2024.
Score components
- +25RoleCEO
- +25Trade size$2.0M at market
- +5Share of holdings soldSold 10% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.6%, 3m -12.1%, 6m -18.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001410442-24-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | MOption exercise Common Stock10b5-1 | +12,000 | $88.76 | $1.1M | 116,593 | Dec 2, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stock10b5-1 | -3,672 | $162.29 | $596k | 112,921 | Dec 2, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stock10b5-1 | -8,250 | $163.18 | $1.3M | 104,671 | Dec 2, 2024 |
| Dec 2, 2024 | SOpen-market sale Common Stock10b5-1 | -78 | $163.96 | $13k | 104,593 | Dec 2, 2024 |
| Dec 2, 2024 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 1,373 | Dec 2, 2024 |
Related signals
Other insiders at ICU MEDICAL INC/DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | ICU MEDICAL INC/DE | Virginia Ruth Sanzone VP, General Counsel | $819k 4,856 shares | -25% | |
| 40Moderate | ICU MEDICAL INC/DE | Brian Michael Bonnell Chief Financial Officer | $1.1M 6,381 shares | -10% | |
| 40Moderate | ICU MEDICAL INC/DE | Brian Michael Bonnell Chief Financial Officer | $1.6M 9,307 shares | -13% | |
| 60Notable | ICU MEDICAL INC/DE | Daniel Woolson VP, GM-Infusion Capital | $982k 5,417 shares | -24% | |
| 56Moderate | ICU MEDICAL INC/DE | Ben Sousa Chief Information Officer | $401k 2,250 shares | -42% | |
| 38Weak | ICU MEDICAL INC/DE | Elisha W Finney director | $69k 378 shares | -7% | |
| 65Notable | ICU MEDICAL INC/DE | Christian B. Voigtlander Chief Operating Officer | $1.6M 8,929 shares | -19% | |
| 49Moderate | ICU MEDICAL INC/DE | Daniel Woolson President | $281k 2,123 shares | -9% | |
| 49Moderate | ICU MEDICAL INC/DE | Virginia Ruth Sanzone VP, General Counsel | $304k 2,447 shares | -11% | |
| 34Weak | ICU MEDICAL INC/DE | David C. Greenberg director | $298k 2,424 shares | -23% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.